Astellas Pharma market cap is ¥3.3 t, and annual revenue was ¥1.30 t in FY 2020. Latest Astellas Pharma Inc (4503:TYO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. ... Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. ASTELLAS PHARMA is trading at 17.05 as of the 22nd of February 2021; that is 1.73 percent up since the beginning of the trading day. Astellas Pharma has a P/B Ratio of 2.65. Get the latest Astellas Pharma Inc (4503) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Astellas Pharma Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. ASTELLAS PHARMA is United States OTC Stock traded on OTC Exchange It Could Be the First of Many More Deals. Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced positive topline results from the second cohort of patients in the pivotal phase 2 single-arm clinical trial known as EV-201. Watch daily 4503 share price chart and data for the last 7 years to develop your own trading strategies. ALPMF: Get the latest Astellas Pharma stock price and detailed information including ALPMF news, historical charts and realtime prices. View Astellas Pharma stock / share price, financial statements, key ratios and more at Craft. Gene-Therapy Firm Audentes Sells for Double Its Share Price. ... Cash Flow per Share… A high-level overview of Astellas Pharma Inc. (ALPMF) stock. The stock's open price was 16.76. Watch daily 4503 share price chart and data for the last 7 years to develop your own trading strategies. Get the Astellas Pharma Inc. stock price history at IFC Markets. Price to Book Value per Share Ratio. ... Astellas Pharma Inc. ADR. Find the latest ASTELLAS PHARMA (ALPMF) stock quote, history, news and other vital information to help you with your stock trading and investing. The P/E ratio of Astellas Pharma is 24.13, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 39.76. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Get the Astellas Pharma Inc. share price history at IFC Markets. Get ASTELLAS PHARMA stock price history and adjusted historical data with charts, graphs, and statistical analysis. View the latest Astellas Pharma Inc. (4503) stock price, news, historical charts, analyst ratings and financial information from WSJ.